drugset
Drugs / Huangqi-Guizhi-Wuwu granules
last change Oct 2022 re-read 3 minutes ago

Huangqi-Guizhi-Wuwu granules

Traditional medicine (herbal / TCM)

Developed for
chemotherapy-induced neuropathy
Investigated by
Fudan University · Jiangsu Cancer Institute & Hospital · Jiangsu Provincial Hospital of Integrated Traditional Chinese and Western Medicine · Nanjing NingQi Medicine Science and Technology Co., Ltd. · The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School · The First Affiliated Hospital with Nanjing Medical University

Trials 1

today NCT04690283 · Ph 3
202120222023202420252026
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 3 NCT04690283 Jan 2021 → Jul 2022 chemotherapy-induced neuropathy, colorectal cancer Nanjing NingQi Medicine Science and Technology Co., Ltd. Unknown No outcome recorded

Evidence & citations 3 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as Huangqi-Guizhi-Wuwu granules ClinicalTrials.gov intervention name — accepted as the source's own label NCT04690283 ↗
Modality Traditional medicine (herbal / TCM) “The intervention relates to a traditional Chinese prescription granules” NCT04690283 ↗
Route Oral “orally take Huangqi Guizhi Wuwu granules twice a day” NCT04690283 ↗